We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
AUM
$286M
AUM Growth
+$12.2M
Cap. Flow
+$9.03M
Cap. Flow %
3.16%
Top 10 Hldgs %
25.32%
Holding
644
New
52
Increased
128
Reduced
112
Closed
63

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.54M
2
TSLA icon
Tesla
TSLA
+$1.91M
3
CAT icon
Caterpillar
CAT
+$1.8M
4
VRNS icon
Varonis Systems
VRNS
+$1.09M
5
MU icon
Micron Technology
MU
+$842K

Sector Composition

Rank Sector Weight
1 Miscellaneous 28.33%
2 Communication Services 14.54%
3 Technology 14.07%
4 Consumer Discretionary 11.03%
5 Healthcare 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBB
551
DELISTED
Cincinnati Bell Inc.
CBB
$3K ﹤0.01%
217
IMDZ
552
DELISTED
Immune Design Corp.
IMDZ
$3K ﹤0.01%
1,000
ADI icon
553
Analog Devices
ADI
$175B
$2K ﹤0.01%
20
CLDX icon
554
Celldex Therapeutics
CLDX
$3.07B
$2K ﹤0.01%
267
DDD icon
555
3D Systems Corp
DDD
$545M
$2K ﹤0.01%
100
FTK icon
556
Flotek Industries
FTK
$867M
$2K ﹤0.01%
167
INVH icon
557
Invitation Homes
INVH
$17.4B
$2K ﹤0.01%
102
KDP icon
558
Keurig Dr Pepper
KDP
$43.8B
$2K ﹤0.01%
107
-56
-34% -$1.77K
RDFN
559
DELISTED
Redfin
RDFN
$2K ﹤0.01%
88
UNM icon
560
Unum
UNM
$14.7B
$2K ﹤0.01%
54
IMNP
561
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$2K ﹤0.01%
31,082
CDXS icon
562
Codexis
CDXS
$174M
$1K ﹤0.01%
74
GYRE icon
563
PUT
Gyre Therapeutics
GYRE
$699M
$1K ﹤0.01%
+9
New +$713
LITE icon
564
Lumentum
LITE
$80.3B
$1K ﹤0.01%
25
TOVX icon
565
Theriva Biologics
TOVX
$11.2M
$1K ﹤0.01%
1
VIAV icon
566
Viavi Solutions
VIAV
$9.02B
$1K ﹤0.01%
125
NMTR
567
DELISTED
9 Meters Biopharma
NMTR
$1K ﹤0.01%
5
VSM
568
DELISTED
Versum Materials, Inc.
VSM
$1K ﹤0.01%
16
AA icon
569
Alcoa
AA
$13.3B
-263
Closed -$12K
AAP icon
570
Advance Auto Parts
AAP
$2.59B
-2,959
Closed -$455K
ACN icon
571
Accenture
ACN
$116B
-6,113
Closed -$1.02M
AGG icon
572
iShares Core US Aggregate Bond ETF
AGG
$138B
-7,896
Closed -$838K
BLK icon
573
Blackrock
BLK
$180B
-1
Closed
BND icon
574
Vanguard Total Bond Market
BND
$161B
-854
Closed -$68K
BRK.A icon
575
Berkshire Hathaway Class A
BRK.A
$1.08T
-800
Closed -$102K

Similar funds

Intellectus Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Intellectus Partners held 644 positions worth $286M, up 4.4% from $274M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Intellectus Partners deployed $9.03M of net new capital in Q3 2018, opening 52 new positions and adding to 128 existing holdings. Its largest new stake was OptimizeRx: 65,000 shares worth $1.17M.

By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 28% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was IBM, an estimated $1.07M trimmed.

  • Intellectus Partners's largest Q3 2018 buy was OptimizeRx: 65,000 shares worth $1.17M.
  • Intellectus Partners added most to Meta Platforms (Facebook) in Q3 2018, an estimated $2.54M increase.
  • Intellectus Partners's biggest Q3 2018 reduction was IBM, cutting an estimated $1.07M.
  • Intellectus Partners fully exited Accenture in Q3 2018, selling an estimated $1.02M.
  • Intellectus Partners's ten largest holdings make up 25% of its $286M portfolio in Q3 2018.
  • Intellectus Partners opened 52 new positions and closed 63 in Q3 2018.
  • Intellectus Partners's portfolio value rose 4.4% quarter-over-quarter to $286M.

Based on Intellectus Partners's 13F filing for Q3 2018, filed 15 Nov 2018.